Padmini S. Pillai, PhD
Special Advisor and DARPA Liaison Officer to Assistant Secretary of War (ND-CBD)
DARPA
Padmini Pillai, Ph.D., is an immunoengineer and national security leader whose work bridges biotechnology, defense innovation, and strategic investment. Dr. Pillai is Special Advisor and DARPA Liaison Officer to Assistant Secretary of War (ND-CBD) HON Dr. Kadlec. She previously served as Special Assistant to the Director of the Biological Technologies Office at DARPA. She was a 2024-25 White House Fellow. Dr. Pillai completed her Ph.D. in Immunobiology at Yale University under the mentorship of Prof. Akiko Iwasaki. Her research, featured in her first-authored Science publication and a Nature Reviews Immunology article, revealed how excessive lung inflammation can drive mortality during flu infections and identified a new potential strategy to boost disease tolerance and improve survival in vulnerable individuals. Inspired to apply her expertise to develop new tools for both treating disease and exploring fundamental questions in immunology, she joined the laboratory of Prof. Robert Langer at MIT and was awarded the CRI Irvington Postdoctoral Fellowship. Her research centered on engineering a tumor-selective RNA nanotherapy to eliminate cancer cells and boost antitumor immunity, for which she was awarded over $2M in funding. Dr. Pillai was named a Young Pioneer at the 2019 World Frontiers Forum and was selected as a 2019 Delegate to the American Academy of Achievement. She has been featured in multiple media outlets including CNBC, The Atlantic, and The New York Times to speak about vaccination, immunity, and respiratory health during the COVID-19 pandemic. Dr. Pillai is a singer and multi-instrumentalist who has performed internationally across genres, from Gospel to South Indian Classical. She has provided backup vocals for Grammy award-winning artist Angélique Kidjo since 2011 at venues including the Kennedy Center, the Lincoln Center, the Newport Jazz Festival, and Carnegie Hall.
Sessions
-
22-Jun-202628ABCDEFrom Detection to Decision: Modernizing Biosurveillance for Early Action




